HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive antibody targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase study tested a radioactive drug designed to seek out and destroy cancer cells in people with advanced solid tumours (like breast, ovarian, or head and neck cancers) that had stopped responding to standard treatments. The drug uses a radioactive particle attached …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called TransCon TLR7/8 Agonist, given as injections into tumors, for people with advanced solid tumors that had stopped responding to standard treatments. The drug was tested alone or with another immunotherapy (pembrolizumab). The main goal…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC